Arcus Biosciences, Inc. (RCUS)
24.41
+0.58
(+2.43%)
USD |
NYSE |
Oct 09, 16:00
24.42
+0.01
(+0.04%)
After-Hours: 20:00
Arcus Biosciences Max Drawdown (5Y) : 85.83% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 85.83% |
| August 31, 2026 | 85.83% |
| July 31, 2026 | 85.83% |
| June 30, 2026 | 85.83% |
| May 31, 2026 | 85.83% |
| April 30, 2026 | 85.83% |
| March 31, 2026 | 85.83% |
| February 28, 2026 | 85.83% |
| January 31, 2026 | 85.83% |
| December 31, 2025 | 85.83% |
| November 30, 2025 | 85.83% |
| October 31, 2025 | 85.83% |
| September 30, 2025 | 85.83% |
| August 31, 2025 | 85.83% |
| July 31, 2025 | 85.83% |
| June 30, 2025 | 85.83% |
| May 31, 2025 | 85.83% |
| April 30, 2025 | 85.83% |
| March 31, 2025 | 83.80% |
| February 28, 2025 | 79.62% |
| January 31, 2025 | 73.39% |
| December 31, 2024 | 72.29% |
| November 30, 2024 | 72.29% |
| October 31, 2024 | 72.29% |
| September 30, 2024 | 72.29% |
| Date | Value |
|---|---|
| August 31, 2024 | 72.29% |
| July 31, 2024 | 72.29% |
| June 30, 2024 | 72.29% |
| May 31, 2024 | 72.29% |
| April 30, 2024 | 72.29% |
| March 31, 2024 | 72.29% |
| February 29, 2024 | 72.29% |
| January 31, 2024 | 72.29% |
| December 31, 2023 | 72.29% |
| November 30, 2023 | 72.29% |
| October 31, 2023 | 70.44% |
| September 30, 2023 | 67.07% |
| August 31, 2023 | 67.07% |
| July 31, 2023 | 67.07% |
| June 30, 2023 | 67.07% |
| May 31, 2023 | 67.07% |
| April 30, 2023 | 67.07% |
| March 31, 2023 | 67.07% |
| February 28, 2023 | 64.45% |
| January 31, 2023 | 64.45% |
| December 31, 2022 | 64.45% |
| November 30, 2022 | 64.45% |
| October 31, 2022 | 64.45% |
| September 30, 2022 | 64.45% |
| August 31, 2022 | 64.45% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Halozyme Therapeutics, Inc. | 49.06% |
| AVITA Medical, Inc. | 88.49% |
| Iovance Biotherapeutics, Inc. | 96.84% |
| Editas Medicine, Inc. | 98.92% |
| Recursion Pharmaceuticals, Inc. | 93.13% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -19.02 |
| Beta (5Y) | 0.9405 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 58.22% |
| Historical Sharpe Ratio (5Y) | -0.1651 |
| Historical Sortino (5Y) | -0.2936 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 24.89% |